Tumor regression grading of gastrointestinal carcinomas after neoadjuvant treatment
Multimodal therapy concepts have been successfully implemented in the treatment of locally advanced gastrointestinal malignancies. The effects of neoadjuvant chemo- or radiochemotherapy such as scarry fibrosis or resorbtive changes and inflammation can be determined by histopathological investigatio...
Main Authors: | Svenja eThies, Rupert eLanger |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-10-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2013.00262/full |
Similar Items
-
Is there a relation between the changes in circulating lymphocyte counts due to neoadjuvant chemoradiotherapy and intratumoral lymphocytic response and tumor regression grade in locally advanced rectal cancers?
by: Necdet Fatih Yasar, et al.
Published: (2017-12-01) -
Outcomes of non-high grade serous carcinoma after neoadjuvant chemotherapy for advanced-stage ovarian cancer: a Korean gynecologic oncology group study (OV 1708)
by: Young Shin Chung, et al.
Published: (2019-04-01) -
Impact of Tumor Regression Grade as a Major Prognostic Factor in Locally Advanced Rectal Cancer after Neoadjuvant Chemoradiotherapy: A Proposal for a Modified Staging System
by: Changhoon Song, et al.
Published: (2018-09-01) -
Tumor Regression Grading Assessment in Locally Advanced Pancreatic Cancer After Neoadjuvant FOLFIRINOX: Interobserver Agreement and Prognostic Implications
by: Andrea Cacciato Insilla, et al.
Published: (2020-02-01) -
Prognostic Value of Tumor Regression Grading in Patients Treated With Neoadjuvant Chemotherapy Plus Surgery for Gastric Cancer
by: Jian-Wei Xie, et al.
Published: (2021-07-01)